Engineering TAG-72 and CD30 CAR-T Cells for T Cell Malignancies
Sign Up to like & getrecommendations! Published in 2025 at "Immunological Investigations"
DOI: 10.1080/08820139.2025.2538049
Abstract: ABSTRACT Background T cell malignancies represent a broad, highly heterogeneous subset of lymphomas with poor prognosis. Chimeric antigen receptor (CAR)-T cell therapy holds great promise in treating B cell lymphoma and multiple myeloma. However, understanding… read more here.
Keywords: tag cd30; car; cell; tumor ... See more keywords